| Extensive somatic L1 retrotransposition in colorectal tumors S Solyom, AD Ewing, EP Rahrmann, T Doucet, HH Nelson, MB Burns, ... Genome research 22 (12), 2328-2338, 2012 | 310 | 2012 |
| A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis BS Moriarity, GM Otto, EP Rahrmann, SK Rathe, NK Wolf, MT Weg, ... Nature genetics 47 (6), 615-624, 2015 | 266 | 2015 |
| Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis EP Rahrmann, AL Watson, VW Keng, K Choi, BS Moriarity, DA Beckmann, ... Nature genetics 45 (7), 756-766, 2013 | 189 | 2013 |
| Multipotent adult progenitor cells from swine bone marrow L Zeng, E Rahrmann, Q Hu, T Lund, L Sandquist, M Felten, TD O'Brien, ... Stem cells 24 (11), 2355-2366, 2006 | 125 | 2006 |
| Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance AL Watson, EP Rahrmann, BS Moriarity, K Choi, CB Conboy, AD Greeley, ... Cancer discovery 3 (6), 674-689, 2013 | 117 | 2013 |
| Identification of PDE4D as a Proliferation Promoting Factor in Prostate Cancer Using a Sleeping Beauty Transposon-Based Somatic Mutagenesis Screen EP Rahrmann, LS Collier, TP Knutson, ME Doyal, SL Kuslak, LE Green, ... Cancer research 69 (10), 4388-4397, 2009 | 114 | 2009 |
| Cancers make their own luck: theories of cancer origins A Jassim, EP Rahrmann, BD Simons, RJ Gilbertson Nature reviews cancer 23 (10), 710-724, 2023 | 108 | 2023 |
| PTEN and NF1 Inactivation in Schwann Cells Produces a Severe Phenotype in the Peripheral Nervous System That Promotes the Development and Malignant … VW Keng, EP Rahrmann, AL Watson, BR Tschida, CL Moertel, WJ Jessen, ... Cancer research 72 (13), 3405-3413, 2012 | 98 | 2012 |
| Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity AL Watson, LK Anderson, AD Greeley, VW Keng, EP Rahrmann, ... Oncotarget 5 (6), 1502, 2014 | 83 | 2014 |
| The NALCN channel regulates metastasis and nonmalignant cell dissemination EP Rahrmann, D Shorthouse, A Jassim, LP Hu, M Ortiz, B Mahler-Araujo, ... Nature genetics 54 (12), 1827-1838, 2022 | 54 | 2022 |
| Sleeping Beauty Insertional Mutagenesis Reveals Important Genetic Drivers of Central Nervous System Embryonal Tumors PJ Beckmann, JD Larson, AT Larsson, JP Ostergaard, S Wagner, ... Cancer research 79 (5), 905-917, 2019 | 54 | 2019 |
| Applications of magnetic resonance imaging for cardiac stem cell therapy C Rickers, R Gallegos, RT Seethamraju, X Wang, C Swingen, A Jayaswal, ... Journal of interventional cardiology 17 (1), 37-46, 2004 | 52 | 2004 |
| Conditional Inactivation of Pten with EGFR Overexpression in Schwann Cells Models Sporadic MPNST VW Keng, AL Watson, EP Rahrmann, H Li, BR Tschida, BS Moriarity, ... Sarcoma 2012 (1), 620834, 2012 | 50 | 2012 |
| Simple and efficient methods for enrichment and isolation of endonuclease modified cells BS Moriarity, EP Rahrmann, DA Beckmann, CB Conboy, AL Watson, ... PloS one 9 (5), e96114, 2014 | 44 | 2014 |
| Using RNA-seq and targeted nucleases to identify mechanisms of drug resistance in acute myeloid leukemia SK Rathe, BS Moriarity, CB Stoltenberg, M Kurata, NK Aumann, ... Scientific reports 4 (1), 6048, 2014 | 36 | 2014 |
| Trp53 haploinsufficiency modifies EGFR-driven peripheral nerve sheath tumorigenesis EP Rahrmann, BS Moriarity, GM Otto, AL Watson, K Choi, MH Collins, ... The American journal of pathology 184 (7), 2082-2098, 2014 | 32 | 2014 |
| Modular assembly of transposon integratable multigene vectors using RecWay assembly BS Moriarity, EP Rahrmann, VW Keng, LS Manlove, DA Beckmann, ... Nucleic acids research 41 (8), e92-e92, 2013 | 26 | 2013 |
| PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcoma BA Smeester, NJ Slipek, EJ Pomeroy, K Laoharawee, SH Osum, ... Bone 136, 115353, 2020 | 24 | 2020 |
| Canonical Wnt/β-catenin signaling drives human Schwann cell transformation, progression, and tumor maintenance. Cancer Discov. 2013; 3: 674–689. doi: 10.1158/2159-8290 AL Watson, EP Rahrmann, BS Moriarity, K Choi, CB Conboy, AD Greeley, ... Cell 152 (5), 1077-90, 2013 | 23 | 2013 |
| SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis BA Smeester, NJ Slipek, EJ Pomeroy, HE Bomberger, GA Shamsan, ... Oncogene 39 (5), 1049-1062, 2020 | 22 | 2020 |
